scholarly journals Alzheimer’s Disease Among American Minority Populations: An Ecological Exploratory Study

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. 350-350
Author(s):  
Maria LaQuaglia ◽  
Marina Celly Martins Ribeiro de Souza ◽  
Carolina Marques Borges

Abstract A significant public health concern with regards to increasing rates of Alzheimer’s is that it disproportionately affects minority groups in the United States. The present ecological exploratory study uses secondary aggregate data from the fifty United States in the year of 2019. The purpose of this study was to address the disparities in Alzheimer’s in minority populations in the US and explore associated factors. The “minority” populations considered were African American and Latino populations, and the “majority” population was referred to as “white”. The data was extracted from the United States Census Bureau, the CDC National Center for Health Statistics, and the Behavioral Risk Factor Surveillance System (BRFSS) Dataset. The prevalence rates of Alzheimer’s disease are greatest in both older Latinos (12.2%) and African Americans (13.8%), compared to older whites (10.3%) in the investigated time period. Our results showed that being over 65 years old (p=.009), with a below-average ($62,843) median household income (p=.024), history of stroke (p=.029), and being a part of the Latino population (p=.036), were significantly associated with Alzheimer’s mortality rates in the United States. By identifying disparities in access to Alzheimer’s healthcare and at-risk communities, more comprehensive intervention strategies can be developed to promote change and advocate for more Alzheimer’s education and resource allocation for minority populations.

2021 ◽  
Vol 3 (1) ◽  
Author(s):  
Maria Laquaglia ◽  
Marina Celly Martins Ribeiro de Souza ◽  
Carolina Marques Borges

A significant public health concern with regards to increasing rates of Alzheimer’s is that it disproportionately affects minority groups in the United States. The present ecological exploratory study uses secondary aggregate data from the fifty United States. The purpose of this study is to address the disparities in Alzheimer’s in minority populations in the US and explore influencing factors. The “minority” populations considered were African American and Latino populations, and the “majority” population was referred to as “white”. The prevalence rates of Alzheimer’s disease were one-and-a-half times greater, and twice as greater in older Latinos and African Americans respectively, compared to older whites in the investigated time period. The data was extracted from the United States Census Bureau, the CDC National Center for Health Statistics, and the Behavioral Risk Factor Surveillance System (BRFSS) Dataset.  The major results from this study showed that being over 65 years old (p=.009), with a below-average median household income (p=.024), history of stroke (p=.029), and being a part of the Latino population (p=.036), are significantly associated with Alzheimer’s mortality rates in the United States. These findings show an association between Alzheimer’s mortality rates and being a part of a minority population in the United States. By identifying disparities in access to Alzheimer’s healthcare and at-risk communities, more comprehensive intervention strategies can be developed to promote change and advocate for more Alzheimer’s education and resource allocation for minority populations. 


2019 ◽  
Author(s):  
Clemens Kruse ◽  
Britney Larson ◽  
Reagan Wilkinson ◽  
Roger Samson ◽  
Taylor Castillo

BACKGROUND Incidence of AD continues to increase, making it the most common cause of dementia and the sixth-leading cause of death in the United States. 2018 numbers are expected to double by 2030. OBJECTIVE We examined the benefits of utilizing technology to identify and detect Alzheimer’s disease in the diagnostic process. METHODS We searched PubMed and CINAHL using key terms and filters to identify 30 articles for review. We analyzed these articles and reported them in accordance with the PRISMA guidelines. RESULTS We identified 11 technologies used in the detection of Alzheimer’s disease: 66% of which used some form of MIR. Functional, structural, and 7T magnetic resonance imaging were all used with structural being the most prevalent. CONCLUSIONS MRI is the best form of current technology being used in the detection of Alzheimer’s disease. MRI is a noninvasive approach that provides highly accurate results in the diagnostic process of Alzheimer’s disease.


1996 ◽  
Vol 17 (4) ◽  
pp. S95
Author(s):  
L. Hebert ◽  
P. Scherr ◽  
L. Beckett ◽  
D. Evans

2014 ◽  
Vol 10 (2) ◽  
pp. e40-e46 ◽  
Author(s):  
Jennifer Weuve ◽  
Liesi E. Hebert ◽  
Paul A. Scherr ◽  
Denis A. Evans

Author(s):  
Angela M Lunde ◽  
Ronald C Petersen ◽  
John A Lucas

In the United States, the National Alzheimer’s Project Act was signed into law in January 2011, and the first National Plan appeared just over 12 months later, with five goals: to prevent and effectively treat Alzheimer’s disease by 2025, to enhance care quality and efficiency, to expand support for people with Alzheimer’s disease and their families, to enhance public awareness and engagement, and to improve data to track progress. The National Plan has seen a rise in research funding (currently standing at US$1.4 billion). Individual states, at the same time, began discussions about initiatives aimed at addressing personal, societal, and financial implications of Alzheimer’s disease. An example is from Minnesota where counselling and support for caregivers are provided, with an estimated saving for the state of Minnesota of US$970 million by 2025. In addition, a number of treatment trials are under way, looking at the effect of monoclonal antibodies on Alzheimer’s disease and a series of genetic studies.


2019 ◽  
Vol 22 ◽  
pp. S280
Author(s):  
K. Saxena ◽  
J. Sullivan ◽  
R. Khandker ◽  
A.S. Ward ◽  
C. Black ◽  
...  

1997 ◽  
Vol 8 (S3) ◽  
pp. 487-490 ◽  
Author(s):  
Jacobo E. Mintzer ◽  
Paul Nietert ◽  
Kerri Costa ◽  
L. Randolph Waid

Alzheimer's disease and other dementing disorders have been reported in most ethnic groups living in the United States. Although the presence of these disorders in different U.S. ethnic groups is well documented, the characteristics of dementing disorders, such as the presence of behavioral disturbances, in these groups remains unexplored.


Sign in / Sign up

Export Citation Format

Share Document